Ovul
PrivateLast Round
SAFE
Nov 12, 2025
Total Funding Raised
$405,000
Company Overview
Ovul is a femtech company that has developed an AI-powered device and platform to track ovulation and hormone levels by analyzing saliva.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Health IoT, D2C Brands
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ovul Comps
Public and private peers based on sector, stage, and business model.
Ovul Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Nov 12, 2025 | ||||
| Accelerator | May 20, 2025 | ||||
| Grant | Jan 16, 2025 |
Key People
Founding team and executive leadership
Ovul Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Google for Startups Ukraine Support Fund | Accelerator |
| SET University | Grant |
| 1991 Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
Raised $1M in a SAFE round.
- May 20, 2025
$100K round from 1991 Accelerator and Google for Startups.
Ovul Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ovul's valuation, stock price, and market status.
